EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes

Armaan Nallicheri, Katherine M Mahoney, Hanna A Gutow, Natalie Bellini, Diana Isaacs

Endocrinology · 2022

DOI: 10.17925/ee.2022.18.1.27 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology, 2022. Verfasst von Armaan Nallicheri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Close Concerns, San Francisco, CA, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This article is published under the Creative Commons Attribution Non-commercial License..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Automated insulin delivery (AID) systems play an important role in the management of type 1 diabetes mellitus (T1DM). These systems include three components: a continuous glucose monitor (CGM), an insulin pump and an algorithm that adjusts the pump based on the CGM sensor glucose readings. They are not fully automated and still require the user to administer bolus insulin doses for food. Some AID systems have automatic correction boluses, while others only have automatic basal or background insulin adjustments. As CGM has become more accurate and the technology has evolved, AID systems have demonstrated improved glycaemic outcomes. The clinical evaluation of AID systems in randomized controlled trials and real-world studies have shown their utility in helping glycaemic management. In this review, we compare AID systems that are commercially available in the US and summarize the literature, with a special focus on time in range in T1DM. The review also discusses new AID systems on the horizon and explores considerations for personalized care.

Schlagwörter

Stichwörter der Autor:innen

Automated insulin deliverycontinuous glucose monitoringdual hormone pumpglycemic managementhybrid closed loop systemtime in rangetype 1 diabetes mellitus

Autor:innen und Institutionen

  • Close Concerns, San Francisco, CA, USA.
  • R&B Medical Group, Williamsville, NY, USA.
  • Cleveland Clinic, Cleveland, OH, USA.

Förderung

  • This article is published under the Creative Commons Attribution Non-commercial License.

Zitieren

APA

Nallicheri, A., Mahoney, K. M., Gutow, H. A., Bellini, N., & Isaacs, D. (2022). Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes. Endocrinology. https://doi.org/10.17925/ee.2022.18.1.27

Vancouver

Nallicheri A, Mahoney KM, Gutow HA, Bellini N, Isaacs D. Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes. Endocrinology. 2022. doi:10.17925/ee.2022.18.1.27

BibTeX
@article{Nallicheri2022,
  author = {Nallicheri, Armaan and Mahoney, Katherine M and Gutow, Hanna A and Bellini, Natalie and Isaacs, Diana},
  title = {Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes},
  journal = {Endocrinology},
  year = {2022},
  doi = {10.17925/ee.2022.18.1.27}
}
Kostenlos starten →